| RS1057519303 |
MAPKBP1
|
Health Risk |
Pathogenic |
Nephronophthisis 20, Nephronophthisis 20 |
| RS1057519304 |
MAPKBP1
|
Health Risk |
Pathogenic |
Nephronophthisis 20, Nephronophthisis 20 |
| RS1057519305 |
MAPKBP1
|
Health Risk |
Pathogenic |
Nephronophthisis 20, Nephronophthisis 20 |
| RS1057519306 |
MAPKBP1
|
Health Risk |
Pathogenic |
Nephronophthisis 20, Nephronophthisis 20 |
| RS1057519307 |
DENND5A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 49 |
| RS1057519308 |
DENND5A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 49 |
| RS1057519310 |
DENND5A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 49 |
| RS1057519311 |
ACTA1
|
Health Risk |
Likely pathogenic |
Actin accumulation myopathy, Actin accumulation myopathy |
| RS1057519312 |
YME1L1
|
Health Risk |
Pathogenic |
Optic atrophy 11, Optic atrophy 11 |
| RS1057519313 |
SLC6A9
|
Health Risk |
Pathogenic |
Atypical glycine encephalopathy, Atypical glycine encephalopathy |
| RS1057519314 |
SLC6A9
|
Health Risk |
Pathogenic |
Atypical glycine encephalopathy, Atypical glycine encephalopathy |
| RS1057519315 |
SLC6A9
|
Health Risk |
Pathogenic |
Atypical glycine encephalopathy, Atypical glycine encephalopathy |
| RS1057519316 |
REEP6
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 77, Retinitis pigmentosa 77 |
| RS1057519317 |
REEP6
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 77, Retinitis pigmentosa 77 |
| RS1057519318 |
EPG5
|
Health Risk |
Likely pathogenic |
Vici syndrome, Vici syndrome |
| RS1057519319 |
TSC1
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS1057519320 |
FBN1
|
Health Risk |
Likely pathogenic |
Marfan syndrome, Congenital contractural arachnodactyly |
| RS1057519321 |
FBN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Congenital contractural arachnodactyly |
| RS1057519322 |
NCLN
|
Health Risk |
Likely pathogenic |
Hirschsprung disease, susceptibility to |
| RS1057519323 |
NUP98
|
Health Risk |
Likely pathogenic |
Hirschsprung disease, susceptibility to |
| RS1057519324 |
NPR2
|
Health Risk |
Pathogenic/Likely pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS1057519325 |
MITF
|
Health Risk |
Pathogenic |
Waardenburg syndrome type 2A, Coloboma |
| RS1057519326 |
MITF
|
Health Risk |
Pathogenic |
Coloboma, osteopetrosis |
| RS1057519327 |
MITF
|
Health Risk |
Pathogenic |
Coloboma, osteopetrosis |
| RS1057519328 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Behcet disease, Familial Mediterranean fever |
| RS1057519329 |
ACOX2
|
Health Risk |
Pathogenic |
Congenital bile acid synthesis defect 6, Congenital bile acid synthesis defect 6 |
| RS1057519330 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1057519333 |
NPR2
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS1057519334 |
NPR2
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS1057519335 |
NPR2
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS1057519336 |
NPR2
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS1057519337 |
AMMECR1
|
Health Risk |
Pathogenic |
Midface hypoplasia, hearing impairment |
| RS1057519338 |
AMMECR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Midface hypoplasia, hearing impairment |
| RS1057519340 |
CPAMD8
|
Health Risk |
Pathogenic |
Anterior segment dysgenesis 8, Anterior segment dysgenesis 8 |
| RS1057519341 |
REEP6
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 77, Retinitis pigmentosa 77 |
| RS1057519342 |
AP5Z1
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 48, Retinal dystrophy |
| RS1057519343 |
COQ8A
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS1057519344 |
COQ8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia due to ubiquinone deficiency, Autosomal recessive ataxia due to ubiquinone deficiency |
| RS1057519347 |
COQ8B
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephrotic syndrome, type 9 |
| RS1057519348 |
COQ2
|
Health Risk |
Likely pathogenic |
Coenzyme Q10 deficiency, Multiple system atrophy 1 |
| RS1057519349 |
COQ6
|
Health Risk |
Pathogenic |
Familial steroid-resistant nephrotic syndrome with sensorineural deafness, Familial steroid-resistant nephrotic syndrome with sensorineural deafness |
| RS1057519350 |
COQ6
|
Health Risk |
Pathogenic |
Familial steroid-resistant nephrotic syndrome with sensorineural deafness, Familial steroid-resistant nephrotic syndrome with sensorineural deafness |
| RS1057519351 |
COQ6
|
Health Risk |
Pathogenic |
Familial steroid-resistant nephrotic syndrome with sensorineural deafness, Familial steroid-resistant nephrotic syndrome with sensorineural deafness |
| RS1057519354 |
PDSS1
|
Health Risk |
Pathogenic |
Deafness-encephaloneuropathy-obesity-valvulopathy syndrome, Deafness-encephaloneuropathy-obesity-valvulopathy syndrome |
| RS1057519355 |
RAD51C
|
Health Risk |
Pathogenic/Likely pathogenic |
Breast-ovarian cancer, familial |
| RS1057519359 |
MTHFR
|
Health Risk |
Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS1057519360 |
MTHFR
|
Health Risk |
Conflicting classifications of pathogenicity |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Neural tube defects |
| RS1057519361 |
MTHFR
|
Health Risk |
Likely pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS1057519362 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS1057519363 |
MTHFR
|
Health Risk |
Pathogenic |
Homocystinuria due to methylene tetrahydrofolate reductase deficiency, Homocystinuria due to methylene tetrahydrofolate reductase deficiency |
| RS1057519364 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary breast ovarian cancer syndrome, Ataxia-telangiectasia syndrome |
| RS1057519365 |
BRIP1
|
Health Risk |
Pathogenic |
Carcinoma of colon, Hereditary cancer-predisposing syndrome |
| RS1057519366 |
FANCC
|
Health Risk |
Pathogenic/Likely pathogenic |
Carcinoma of colon, Hereditary cancer-predisposing syndrome |
| RS1057519367 |
REV3L
|
Health Risk |
Likely pathogenic |
Carcinoma of colon, Carcinoma of colon |
| RS1057519368 |
PTEN
|
Health Risk |
Pathogenic |
Macrocephaly-autism syndrome, PTEN hamartoma tumor syndrome |
| RS1057519369 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1057519370 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1057519371 |
HNF1B
|
Health Risk |
Pathogenic |
Renal cysts and diabetes syndrome, Renal cysts and diabetes syndrome |
| RS1057519374 |
SEMA3D
|
Health Risk |
Pathogenic |
Progressive sensorineural hearing impairment, SEMA3D-related disorder |
| RS1057519375 |
EP300
|
Health Risk |
Pathogenic |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency, Rubinstein-Taybi syndrome due to EP300 haploinsufficiency |
| RS1057519376 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS1057519377 |
COL4A3
|
Health Risk |
Pathogenic |
Autosomal dominant Alport syndrome, Autosomal dominant Alport syndrome |
| RS1057519378 |
CARD10
|
Health Risk |
risk factor |
Primary open angle glaucoma, Primary open angle glaucoma |
| RS1057519379 |
CTNNB1
|
Health Risk |
Pathogenic |
Exudative vitreoretinopathy 1, Severe intellectual disability-progressive spastic diplegia syndrome |
| RS1057519380 |
CTNNB1
|
Health Risk |
Pathogenic |
Exudative vitreoretinopathy 1, Exudative vitreoretinopathy 7 |
| RS1057519381 |
MED12
|
Health Risk |
Likely pathogenic |
FG syndrome 1, FG syndrome 1 |
| RS1057519383 |
ADGRV1
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS1057519384 |
CDC73
|
Health Risk |
Pathogenic |
Ossifying fibroma of the jaw, Ossifying fibroma of the jaw |
| RS1057519385 |
CDC73
|
Health Risk |
Pathogenic |
Ossifying fibroma of the jaw, Ossifying fibroma of the jaw |
| RS1057519389 |
EBF3
|
Health Risk |
Pathogenic |
Ataxia, Intellectual disability |
| RS1057519392 |
POGZ
|
Health Risk |
Likely pathogenic |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome, Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome |
| RS1057519393 |
KDM5C
|
Health Risk |
Pathogenic |
Syndromic X-linked intellectual disability Claes-Jensen type, Syndromic X-linked intellectual disability Claes-Jensen type |
| RS1057519394 |
SLC9A6
|
Health Risk |
Pathogenic |
Christianson syndrome, Christianson syndrome |
| RS1057519395 |
SHANK3
|
Health Risk |
Pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS1057519396 |
CUL4B
|
Health Risk |
Pathogenic |
X-linked intellectual disability Cabezas type, X-linked intellectual disability Cabezas type |
| RS1057519398 |
SMC1A
|
Health Risk |
Pathogenic |
Congenital muscular hypertrophy-cerebral syndrome, Congenital muscular hypertrophy-cerebral syndrome |
| RS1057519399 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS1057519400 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1057519402 |
DYRK1A
|
Health Risk |
Pathogenic |
DYRK1A-related intellectual disability syndrome, DYRK1A-related intellectual disability syndrome |
| RS1057519403 |
KMT2A
|
Health Risk |
Likely pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1057519404 |
MECP2
|
Health Risk |
Pathogenic |
X-linked intellectual disability-psychosis-macroorchidism syndrome, X-linked intellectual disability-psychosis-macroorchidism syndrome |
| RS1057519405 |
SYNGAP1
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 5 |
| RS1057519406 |
SHANK3
|
Health Risk |
Likely pathogenic |
Phelan-McDermid syndrome, Phelan-McDermid syndrome |
| RS1057519407 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1057519408 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1057519413 |
RAD51
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group R, RAD51-related disorder |
| RS1057519414 |
NDUFA10
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 22 |
| RS1057519415 |
NDUFA10
|
Health Risk |
Pathogenic |
Mitochondrial complex I deficiency, nuclear type 22 |
| RS1057519416 |
SLC25A46
|
Health Risk |
Pathogenic |
Neuropathy, hereditary motor and sensory |
| RS1057519417 |
TMTC3
|
Health Risk |
Pathogenic |
Lissencephaly 8, Lissencephaly 8 |
| RS1057519418 |
ANOS1
|
Health Risk |
Likely pathogenic |
Hypogonadotropic hypogonadism 1 with or without anosmia, Hypogonadotropic hypogonadism 1 with or without anosmia |
| RS1057519419 |
CDC73
|
Health Risk |
Likely pathogenic |
Hyperparathyroidism 1, Parathyroid carcinoma |
| RS1057519420 |
HSD17B4
|
Health Risk |
Likely pathogenic |
— |
| RS1057519422 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1057519423 |
CHD7
|
Health Risk |
Pathogenic |
CHARGE syndrome, CHARGE syndrome |
| RS1057519424 |
PLPBP
|
Health Risk |
Pathogenic |
Epilepsy, early-onset |
| RS1057519425 |
PIEZO2
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS1057519426 |
PIEZO2
|
Health Risk |
Pathogenic |
Arthrogryposis, distal |
| RS1057519427 |
REEP6
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 77, Retinitis pigmentosa 77 |
| RS1057519429 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebellar ataxia, Intellectual disability |